United Therapeutics | UTHR - Current Liabilities

Stock Price
477.51
Daily Change
2.51 0.53%
Monthly
-2.49%
Yearly
35.11%
Q1 Forecast
455.03

United Therapeutics reported $546.3M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Amarin USD 182.23M 3.71M Sep/2025
Ardelyx USD 83.39M 1.67M Sep/2025
Baxter International USD 3.78B 836M Sep/2025
Bayer EUR 28.96B 825M Sep/2025
Biogen USD 3.29B 106.3M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Gilead Sciences USD 12.3B 1.11B Sep/2025
GlaxoSmithKline GBP 21.33B 956M Sep/2025
Halozyme Therapeutics USD 837.23M 702.95M Sep/2025
Insmed USD 417.21M 105.53M Sep/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
J&J USD 50.87B 3.31B Sep/2025
Moderna USD 1.68B 109M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
PTC Therapeutics USD 866.24M 238.44M Sep/2025
Regeneron Pharmaceuticals USD 4.43B 758.1M Sep/2025
Sarepta Therapeutics USD 921.42M 1.48M Sep/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
United Therapeutics USD 546.3M 19.2M Sep/2025
Vertex Pharmaceuticals USD 4.48B 336.9M Sep/2025